These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18722865)

  • 21. A biomarker profile for predicting efficacy of cisplatin-vinorelbine therapy in malignant pleural mesothelioma.
    Zimling ZG; Sørensen JB; Gerds TA; Bech C; Andersen CB; Santoni-Rugiu E
    Cancer Chemother Pharmacol; 2012 Nov; 70(5):743-54. PubMed ID: 22960937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisplatin, mitomycin, and interferon-alpha2a combination chemoimmunotherapy in the treatment of diffuse malignant pleural mesothelioma.
    Metintas M; Ozdemir N; Uçgun I; Elbek O; Kolsuz M; Mutlu S; Metintas S
    Chest; 1999 Aug; 116(2):391-8. PubMed ID: 10453867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: result in a cohort of 203 resection specimens.
    Mujoomdar AA; Tilleman TR; Richards WG; Bueno R; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):352-5. PubMed ID: 20653100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
    Rusch VW; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M
    J Clin Oncol; 1992 Jun; 10(6):1001-6. PubMed ID: 1588364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vinorelbine for non-small cell lung cancer].
    Seto T
    Nihon Rinsho; 2002 May; 60 Suppl 5():353-8. PubMed ID: 12101688
    [No Abstract]   [Full Text] [Related]  

  • 26. [A case of remission induced in diffuse pleural malignant mesothelioma by the treatment with cisplatin and doxorubicin].
    Niki Y; Nakayama S; Soga T; Baba M; Nishimura A; Kato M; Kanamaru M
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3635-8. PubMed ID: 2817912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chemotherapy of malignant pleural mesothelioma: have we made any progress?].
    Reck M; Heigener DF; Gatzemeier U
    Zentralbl Chir; 2008 Jun; 133(3):238-42. PubMed ID: 18563688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care?
    Rusch VW
    J Clin Oncol; 2003 Jul; 21(14):2629-30. PubMed ID: 12860935
    [No Abstract]   [Full Text] [Related]  

  • 29. [Results of phase II clinical trial of cycloplatam in refractory solid tumors].
    Bagrova SG
    Vopr Onkol; 2001; 47(6):752-6. PubMed ID: 11826504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of pemetrexed plus cisplatin: malignant pleural mesothelioma treatment in UK clinical practice.
    Cordony A; Le Reun C; Smala A; Symanowski JT; Watkins J
    Value Health; 2008; 11(1):4-12. PubMed ID: 18237355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma.
    Fennell DA; C Steele JP; Shamash J; Sheaff MT; Evans MT; Goonewardene TI; Nystrom ML; Gower NH; Rudd RM
    Lung Cancer; 2005 Feb; 47(2):277-81. PubMed ID: 15639727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case report of malignant pleural mesothelioma with long-term disease control after chemotherapy.
    Umsawasdi T; Dhingra HM; Charnsangavej C; Luna MA
    Cancer; 1991 Jan; 67(1):48-54. PubMed ID: 1898706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation.
    Lewis R; Bagnall AM; King S; Woolacott N; Forbes C; Shirran L; Duffy S; Kleijnen J; ter Riet G; Riemsma R
    Health Technol Assess; 2002; 6(14):1-269. PubMed ID: 12583816
    [No Abstract]   [Full Text] [Related]  

  • 34. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
    Anand A; Anand A; Anand N
    Cancer; 1996 May; 77(9):1959-60. PubMed ID: 8646700
    [No Abstract]   [Full Text] [Related]  

  • 35. [A case of remission in diffuse pleural mesothelioma induced by anticancer chemotherapy with cisplatin and adriamycin].
    Kinoshita S; Yamashita T; Yagi M; Bando H; Tsubura E; Sano T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1872-6. PubMed ID: 4041164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pemetrexed-cisplatin combination in mesothelioma.
    Reck M; Gatzemeier U
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):231-7. PubMed ID: 15877521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant mesothelioma.
    Muñoz A; Barceló R; López-Vivanco G
    N Engl J Med; 2006 Jan; 354(3):305-7; author reply 305-7. PubMed ID: 16422026
    [No Abstract]   [Full Text] [Related]  

  • 38. Local treatment of malignant pleural mesothelioma with intracavitary cytosine-arabinoside and cisplatin.
    Aitini E; Pasquini E; Cavazzini G; Fattori PP; Smerieri F
    Ann Oncol; 1992 Nov; 3(9):771-2. PubMed ID: 1450068
    [No Abstract]   [Full Text] [Related]  

  • 39. Low ERCC1 expression in malignant pleural mesotheliomas treated with cisplatin and vinorelbine predicts prolonged progression-free survival.
    Zimling ZG; Sørensen JB; Gerds TA; Bech C; Andersen CB; Santoni-Rugiu E
    J Thorac Oncol; 2012 Jan; 7(1):249-56. PubMed ID: 22031231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A diffuse, pleural, malignant mesothelioma kept in long remission by chemotherapy combining pirarubicin and cisplatin].
    Niki Y; Soga T; Nishimura A; Kato M; Hamada M; Kanamaru M
    Gan No Rinsho; 1990 Nov; 36(14):2463-7. PubMed ID: 2250368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.